Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay

John P. Alao, Jeanette Olesch and Per Sunnerhagen
John P. Alao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanette Olesch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per Sunnerhagen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-09-0218 Published September 2009
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Histone deacetylase (HDAC) inhibitors potently inhibit tumor growth and are currently being evaluated for their efficacy as chemosensitizers and radiosensitizers. This efficacy is likely to be limited by the fact that HDAC inhibitors also induce cell cycle arrest. Deletion of the class I HDAC Rpd3 has been shown to specifically suppress the sensitivity of Saccharomyces cerevisiae DNA damage checkpoint mutants to UV and hydroxyurea. We show that in the fission yeast Schizosaccharomyces pombe, inhibition of the homologous class I HDAC specifically suppresses the DNA damage sensitivity of checkpoint mutants. Importantly, the prototype HDAC inhibitor Trichostatin A also suppressed the sensitivity of DNA damage checkpoint but not of DNA repair mutants to UV and HU. TSA suppressed DNA damage activity independently of the mitogen-activated protein kinase–dependent and spindle checkpoint pathways. We show that TSA delays progression into mitosis and propose that this is the main mechanism for suppression of the DNA damage sensitivity of S. pombe checkpoint mutants, partially compensating for the loss of the G2 checkpoint pathway. Our studies also show that the ability of HDAC inhibitors to suppress DNA damage sensitivity is not species specific. Class I HDACs are the major target of HDAC inhibitors and cancer cells are often defective in checkpoint activation. Effective use of these agents as chemosensitizers and radiosensitizers may require specific treatment schedules that circumvent their inhibition of cell cycle progression. [Mol Cancer Ther 2009;8(9):2606–15]

Keywords
  • Trichostatin A
  • radiosensitization
  • cell cycle delay
  • G2 checkpoint

Introduction

A functional DNA damage checkpoint pathway is essential for maintaining genomic integrity by facilitating the repair of damaged DNA. In S. pombe, the DNA damage checkpoint is regulated in a rad3+-dependent (ATM/ATR homologue) manner by a signaling cascade that involves Rad26, Rad17, Rad9, Rad1, Hus1, Crb2, Mrc1, Chk1, and Cds1 (1). Activation of this pathway in response to DNA damage ultimately leads to inactivation of Cdc2 activity and cell cycle arrest (the DNA damage checkpoint). At the same time, the repair of DNA lesions is also activated and cell cycle arrest allows time for DNA damage repair to take place. The importance of this pathway is underscored by the extreme sensitivity of DNA damage checkpoint and repair mutants to DNA-damaging agents. It has also become clear that the regulation of chromatin architecture is important for the detection/recognition and repair of DNA damage and the recovery/resetting of higher order chromatin structure following repair (2).

Histone acetyl transferases and histone deacetylases (HDAC) regulate gene expression and chromatin structure by modulating the acetylation status of lysine residues in core histones within chromatin (3). Early studies reported that UV-induced DNA damage resulted in an increase in global histone acetylation levels (4). Genetic studies have also shown that both histone acetyl transferase and HDAC mutants are sensitive to DNA-damaging agents and impaired in their ability to repair damaged DNA (5, 6). It is likely that the global changes in acetylation following DNA damage modulate gene expression and allow DNA repair proteins to access the damaged DNA within chromatin. HDAC activity is commonly deregulated in cancer cells. Small molecule inhibitors of HDAC activity have proven effective at inhibiting cancer cell proliferation in vitro and in vivo. As a consequence, several HDAC inhibitors (HDACi) have entered clinical trials with encouraging results (7, 8). Of particular interest has been the observation that HDACis can sensitize cancer cells to the effects of conventional DNA-damaging agents used in the treatment of cancer (9–11). Similarly, S. pombe mutants that have mutations within the clr6+ HDAC gene, or fail to express its associated cofactors, are sensitive to DNA-damaging agents (6). Interestingly, inhibition of HDAC activity has been shown to suppress the sensitivity of Saccharomyces cerevisiae checkpoint mutants to DNA damage and replication stress. Scott and Plon (12) observed that deletion of the RPD3 HDAC gene or its cofactor SIN3 enhanced the viability of the mec1Δ and rad9Δ checkpoint mutants following exposure to hydroxyurea (HU) or UV radiation. The suppression of sensitivity was shown to involve a RAD53-independent checkpoint and require a functional spindle checkpoint pathway. In many cancer cells, the ability to effectively detect and repair DNA damage is impaired. Indeed, mutations within genes that regulate DNA damage repair have been causally liked to the development and progression of cancer and the response to therapy (13, 14). The use of HDACis as hemosensitizers and radiosensitizers may thus be contraindicated in cancer cells in which the DNA damage response pathway is impaired.

In the current study, we set out to (a) determine if inhibition of HDAC activity suppresses the sensitivity of S. pombe DNA damage checkpoint and repair mutants to DNA damage, (b) to identify the specific HDAC proteins involved in the suppression of sensitivity, and (c) to characterize the molecular mechanisms that underlie the suppression sensitivity to DNA damage. We present evidence that the HDACi trichostatin A (TSA) suppresses the sensitivity of S. pombe checkpoint mutants to UV-induced DNA damage. A clr6-1 rad1Δ double mutant displayed significantly reduced sensitivity to UV radiation compared with rad1Δ single mutants. In contrast, deletion of the clr3+ and hos2+/hda1+ genes did not suppress sensitivity to DNA damage. In rad1Δ mutants, TSA attenuated UV-induced mitotic stimulation (15) but did not restore a normal DNA damage checkpoint. Furthermore, TSA did not induce Chk1 or Cdc2 phosphorylation in UV-exposed rad3Δ mutants and suppressed the UV sensitivity of cds1Δ chk1Δ double mutants. Similarly, clr6-1 rad1Δ double mutants underwent a reduced rate of cell division compared with rad1Δ mutants following UV exposure. HDAC inhibition did not, however, suppress the UV sensitivity of rad13Δ and rhp51Δ mutants that are defective in nucleotide excision repair (NER) and recombination, respectively. Our studies indicate that suppression of Clr6 activity modulates global histone acetylation and delays cell cycle progression. Together, these effects significantly suppress the UV sensitivity of S. pombe DNA damage checkpoint mutants.

Materials and Methods

All strains (Table 1) were cultured on YES agar or in YES broth (0.5% yeast extract, 3% glucose, and 225 mg/liter each of adenine, histidine, leucine, lysine, and uracil) at 30°C except where indicated. DNA constructs and chromosomal disruptions were done as previously described (16, 17). Stock solutions of TSA (10 mg/mL; Errant Gene Therapeutics) in ethanol were stored at −20°C. Bleomycin stock solution (Sigma Aldrich) was made up according to the manufacturer's instructions and stored at −20°C. Stock solutions of HU (1 mol/L; Sigma-Aldrich) were stored at −20°C.

View this table:
  • View inline
  • View popup
Table 1.

S. pombe strain list

Measurement of Survival after UV Irradiation

Cells were grown overnight in liquid medium until early or mid-log phase was reached. Cells were pelleted by brief centrifugation and resuspended in 25 mL of sterile water. A UVGL-58 short wave UV lamp with an emission peak of 254 nm was used as a UV source under conditions of continuous agitation. Following irradiation, cells were collected by centrifugation and resuspended in liquid medium with or without 20 μg/mL of TSA for 2 or 4 h. The cells were then equilibrated to an OD600 nm of 0.2, serially diluted, spotted on plates, and incubated for 2 to 3 d at the indicated temperature. Alternatively, cells were grown to stationary phase and then diluted into fresh medium at an OD600 nm of 0.2. The cells were then cultured at 30°C for 4 h to allow reentry into the cell cycle, serially diluted, and spotted on YES agar plates supplemented with the indicated compounds. The spotted cultures were allowed to dry in air and were then exposed to the appropriate dose of UV.

Measurement of Survival after Exposure to HU or Bleomycin

Early- to mid-log phase cultures were treated with 20 mmol/L HU alone or with 20 μg/mL TSA and incubated for 4 h with shaking at 30°C. Alternatively, cells were incubated with 1.5 mU/mL bleomycin alone or with 20 μg/mL TSA for 2 h. Following incubation, the cultures were equilibrated to an OD600 nm of 0.2 to 0.3, serially diluted, spotted, and incubated for 2 to 3 d at the indicated temperature.

Immunoblot Analyses

Cells were harvested by centrifugation and processed immediately or snap frozen in an ethanol bath and stored at −80°C. The cells were lysed in buffer A [50 mmol/L Tris-HCl (pH 8.0), 50 mmol/L NaCl, 0.2% Triton X-100, and 1% NP40] supplemented with Complete protease inhibitor and phosphatase inhibitor cocktails (Roche), using a FastPrep SP120 apparatus (Savant, Inc.) with a speed setting of 5.0 for 20 s. Lysates were resolved on 7%, 10%, or 15% SDS-polyacrylamide gels and transferred to nitrocellulose membranes using a semidry blotting apparatus. Proteins were detected using an anti-HA or anti-Myc probe (Santa Cruz Biotechnology), anti–phospho-Cdc2, anti–α tubulin (Sigma), anti-Cdc2 (Abcam), anti-acetyl H3 (K9, K14), and anti-acetyl H4 (K5, K8, K12; Upstate Biotechnology, Millipore AB). Horseradish peroxidase–conjugated secondary antibodies and the enhanced chemiluminescence Western blotting system (General Electric Bio-Sciences) were used for detection.

4′, 6′-Diamidino-2-phenylindole and Calcofluor Staining for Fluorescence Microscopy

Cells were washed, fixed in 70% ethanol, and mounted in Vectashield mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI; Vector Laboratories Ltd.) to counterstain DNA. Calcofluor staining of septa was carried out as described (18). Briefly, washed and fixed cells were mounted in 50 μg/mL calcofluor (Sigma-Aldrich). Stained cells were examined by fluorescence microscopy and at least 300 cells were scored for septation assays.

Fluorescence-Activated Cell Sorting

Approximately 107 cells were harvested at the desired time points, resuspended in 70% ethanol, and stored at 4°C until use. Fluorescence-activated cell sorting (FACS) analyses were done according to the protocol of Sazer and Sherwood (19), using propidium iodide (32 μg mL−1) as outlined on the Forsburg lab page.1 Flow cytometry was done with a BD FACSAria cell sorting system (Becton Dickinson AB).

Results

TSA Suppresses UV and HU Sensitivity in S. pombe Checkpoint Mutants

Deletion of the class I HDAC gene, RPD3, has been shown to suppress DNA damage sensitivity in S. cerevisiae checkpoint mutants (12). To determine if the inhibition of HDAC activity in S. pombe checkpoint mutants would also suppress UV sensitivity, early-log phase cultures of wild-type (wt) and checkpoint mutant strains were UV irradiated and cultured with or without TSA (Fig. 1A). Wt cells exhibited little sensitivity to UV and this was not affected by TSA. As expected, the rad3-136, rad3Δ, rad1Δ, chk1Δ, and wee1Δ mutants were extremely sensitive to UV. When these mutants were cultured in YES medium containing TSA however, a significant increase in the survival was observed following UV exposure. The survival of rad3-136, hus1Δ, and rad1Δ mutants was also significantly enhanced when plated on YES agar containing TSA followed by exposure to UV (Supplementary Fig. S1A). Clr6, Hos2, and Clr3 are S. pombe class I/II HDACs, and of these, Clr6 has been shown to be sensitive to TSA (6). We generated clr6-1 rad1Δ, hos2Δ rad1Δ, and clr3Δ rad1Δ double mutants to compare their relative sensitivity to UV. Culture of the clr6-1 rad1Δ mutant at the semipermissive temperature (30°C) significantly suppressed UV sensitivity, an effect not observed at the permissive temperature, 25°C (Fig. 1B). In contrast, the hos2Δ rad1Δ and clr3Δ rad1Δ double mutants failed to grow following exposure to UV (Fig. 1B). Inhibition of HDAC activity by TSA also suppressed the sensitivity of the rad3Δ, rad1Δ, hus1Δ, and cdc2-3w mutants to HU (Fig. 1C). Similarly, clr6-1 rad1Δ double mutants grown at the semirestrictive temperature (30°C) were considerably less sensitive to HU than rad1Δ single mutants (Fig. 1D). FACS analyses further showed that progression through mitosis is delayed in clr6-1 and clr6-1 rad1Δ mutants at 30°C (Fig. 1D). However, TSA did not suppress the sensitivity of the rad3-136 mutant to bleomycin (Supplementary Fig. S1B). cds1 mutants undergo a Chk1-dependent cell cycle arrest when exposed to HU, but nevertheless lose viability due to their inability to resume DNA replication (20). In contrast, cdc2-3w mutants lose viability because they undergo mitosis in the absence of DNA replication when exposed to HU (21, 22). TSA suppressed the HU sensitivity of cdc2-3w but not cds1Δ mutants suggesting that the HDACi delays cell cycle progression (Fig. 1C). Accordingly, TSA also suppresses the UV sensitivity of chk1Δ and wee1Δ mutants (Fig. 1A), which are specifically defective in enforcing the G2 DNA damage checkpoint (1).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Inhibition of HDAC activity suppresses the UV sensitivity of S. pombe checkpoint mutants. A, the indicated strains were grown to mid-log phase, resuspended in sterile water, and exposed to 120 or 240 Jm−2 (wee1Δ) UV. Cells were then resuspended in YES medium ± 20 μg/mL TSA and incubated for 4 h at 30°C with shaking. Cells were then serially diluted, spotted onto YES plates, and incubated for 2 to 3 d at 30°C. B, cells were treated as in A and incubated at either 30°C (semipermissive temperature for clr6-1) or 25°C (permissive temperature for clr6-1). clr3 and clr3 rad1 mutants were treated as in A. C, the effect of TSA on HU sensitivity of rad3Δ, rad1Δ, hus1Δ, cdc2-3w, and cds1Δ cells was investigated. Strains were incubated with 20 mmol/L HU ± 20 μg/mL TSA for 4 h, serially diluted, and plated on normal media. Plates were incubated at 30°C for 2 to 3 d. D, the indicated strains were incubated with 20 mmol/L HU for 4 h at 30°C and treated as in C. Samples were also harvested at the indicated time points and analyzed by FACS.

TSA Delays Cell Cycle Progression of S. pombe Checkpoint Mutants

S. pombe DNA damage checkpoint mutants fail to undergo cell cycle arrest when exposed to DNA-damaging agents and accumulate as septated cells (23, 24). Septation indices were monitored to determine cell cycle progression following UV exposure (120 Jm−2) with or without 20 μg/mL TSA (Fig. 2A). Mitotic division decreased rapidly in wt cells as monitored by the decrease in the number of septating cells and was not affected by TSA (Fig. 2A, I). In contrast, exposure of the rad3-136, rad1Δ, and chk1Δ mutants to UV did not result in cell cycle arrest (Fig. 2A, II–IV). As previously reported, exposure of rad3-136, rad1Δ, and chk1Δ mutants to UV resulted in an increase in the number of septated cells (Fig. 2A, II–IV). Addition of TSA to the culture medium prevented the accumulation of septated cells but did not restore a wt checkpoint in rad3-136, rad1Δ, and chk1Δ mutants; instead, the septation profiles were suggestive of a mitotic delay as the peak of septated cells was delayed or absent (Fig. 2A, II–IV). Similarly, attenuation of Clr6 activity also prevented the accumulation of septated cells when clr6-1 rad1Δ double mutants were exposed to UV (Fig. 2B). TSA did not restore Chk1 phosphorylation in a rad3Δ mutant or influence Cdc2 phosphorylation in rad1Δ mutants following UV exposure (Fig. 2C and D). Rather, the Chk1 level was lowered in rad3Δ mutants exposed to TSA. Together, these observations suggest that the suppression of Clr6 HDAC activity delays cell cycle progression independently of Cdc2 phosphorylation.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

HDAC inhibition delays cell cycle progression in checkpoint mutants exposed to UV. A, the indicated strains were irradiated in sterile water and then incubated in YES medium ± 20 μg/mL TSA and incubated for 4 h at 30°C with shaking. Samples were harvested at the indicated time points, stained with calcofluor, and the septation index determined by microscopy. B, clr6-1, clr6-1 rad1Δ, and rad1Δ strains were irradiated in sterile water and then incubated in YES medium and incubated for 4 h at 30°C with shaking. Samples harvested at the indicated time points were treated as in A. C, Wt and rad3Δ mutant strains expressing HA epitope-tagged Chk1 were irradiated as in A and incubated for 2 h at 30°C with shaking. Total protein lysates were resolved by SDS-PAGE and probed with antibodies directed against HA and α-tubulin. D, Wt and rad1Δ mutants were treated as in C and probed with antibodies directed against phospho- and total Cdc2.

To determine where in the cell cycle the TSA-induced delay takes place, we next undertook analyses of cell cycle progression by microscopy, septation assays, and flow sorting. To determine if HDAC inhibition delays progression through G2, we released cdc25-22 mutants, synchronized in early G2 by incubating for 4 h at 36°C, into the cell cycle in the presence or absence of 20 μg/mL TSA. In the absence of TSA, cdc25-22 cells rapidly proceeded through mitosis into the subsequent G1-S phase as indicated by the large number of binuclear and/or septated cells detectable between 80 and 140 minutes after release. In the presence of TSA, progression into mitosis was clearly delayed and the mitotic index did not peak until 140 to 160 minutes after release (Fig. 3A and B). FACS analyses further showed a marked difference in cell cycle kinetics between TSA-treated and untreated cells from Fig. 3A and B (Fig. 3C). In contrast, TSA did not affect progression into S phase when cdc10-M17 mutants, synchronized in G1 by incubation at the restrictive temperature, were downshifted to 25°C (Fig. 3D). In S. pombe, S phase, septum formation, and cytokinesis are dependent on the completion of the preceding mitosis (25, 26). Our results thus strongly suggest that TSA delays entry into and/or progression through mitosis. Because cytokinesis occurs after the completion of S phase in S. pombe however, we could not rule out the possibility that TSA also delays cell cycle progression between the completion of mitosis, the subsequent G1-S phase and/or cytokinesis. When asynchronous populations of rad3Δ mutants were exposed to HU and monitored by FACS (Fig. 4A), TSA delayed progression into S phase. In the presence of 20 mmol/L HU alone, within 2 hours, a majority of the cell population had proceeded through one round of mitosis and daughter cells accumulated with a predominantly <2C DNA content. In the presence of TSA however, a significant proportion of the cell population remained in G2 at 2 hours after drug exposure, indicating that these cells had not yet progressed through mitosis and/or cytokinesis. Coculture with TSA also reduced the number of cells with chromosome segregation defects (cut phenotype) when rad3-136 or cdc2-3w mutants were exposed to HU (Fig. 3B and D). We noted that rad3-136 mutants cocultured with HU and TSA were longer at cell division when compared with cells cultured in the presence of HU alone (Fig. 3C). In cells with a defective G2 checkpoint attempting mitosis in the presence of DNA damage, chromosomal missegregation will occur. Taken together, our findings suggest that a mitotic delay is the main mechanism by which HDAC inhibition suppresses the DNA damage sensitivity of checkpoint mutants. This delay provides additional time for DNA repair, thus reducing the number of cells with chromosomal segregation defects.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

TSA delays entry into mitosis. A, cdc25-22 cells were synchronized in early G2 by incubation at 36°C for 4 h and released into the cell cycle by incubating at 25°C ± 20 μg/mL TSA, and samples were harvested at the indicated time points. Cells stained with calcofluor or DAPI and the mitotic and septation indices determined by fluorescence microscopy. Points, mean of three experiments; bars, SD. B, cdc25-22 cells were treated as in A, stained with DAPI, and examined by fluorescence microscopy. C, cdc25-22 cells from A were harvested at the indicated time points after release and analyzed by FACS. D, cdc10-M17 cells were synchronized in G1-S by incubation at 36°C for 4 h and released into the cell cycle by incubating at 25°C ± 20 μg/mL TSA. Samples were harvested at the indicated time points and analyzed by FACS.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

TSA delays entry into mitosis. A, rad3Δ cells were incubated with 20 mmol/L HU ± 20 μg/mL TSA. Samples were harvested at the indicated time points and analyzed by FACS. B, rad3-136 cells were incubated with 20 mmol/L HU ± 20 μg/mL TSA and harvested at the indicated times. Cells were fixed, stained with DAPI, and the percentage of cells with chromosome missegregation (cuts) was determined by fluorescence microscopy. cdc2-3w cells were incubated for 4 h at 30°C as indicated, fixed, and analyzed in the same manner as the rad3-136 cells. Columns, mean of three experiments; bars, SD. C, rad3Δ cells were treated as in B for 4 h, fixed, stained with calcofluor, and examined by fluorescence and DIG microscopy. Values indicate average cell length at division ± 1 SD. D, cdc2-3w cells were treated as in B. White arrows, cut cells.

TSA-Mediated Suppression of DNA Damage Sensitivity Occurs Independently of the Mitogen-Activated Protein Kinase or Spindle Checkpoint Pathways

HDAC inhibition has been shown to delay mitosis in a manner dependent on the p38 mitogen-activated protein kinase (27). Deletion of sty1+ (the p38 homologue in S. pombe) in a rad1Δ background did not prevent the suppressive effect of TSA following exposure to UV (Fig. 4A). Interestingly, TSA also suppressed the UV sensitivity of sty1Δ mutants (Fig. 5A). Srk1, a downstream target of Sty1, has also been shown to delay G2 progression in S. pombe (28). Deletion of srk1+ in a rad1Δ background did not suppress the protective effect of TSA, however (Fig. 5A). In S. cerevisiae, HDAC inhibition induces an alternative Mad1-dependent cell cycle delay when checkpoint mutants are exposed to agents that damage DNA (12). Codeletion of the S. pombe spindle checkpoint regulator gene mad2+ did not affect the ability of TSA to suppress UV sensitivity in rad1Δ mutants (Fig. 5A). Our findings indicate that HDAC inhibition delays cell cycle progression in S. pombe independently of Sty1, Srk1, and the spindle checkpoint pathway.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Role of checkpoints and DNA repair in TSA-mediated suppression of UV sensitivity. A, indicated strains were treated as in Fig. 1 except that the sty1Δ rad1Δ double mutant was exposed to 60 Jm2 UV. B to C, Wt cells were exposed to 120 Jm−2 UV and incubated in YES medium for the indicated times at 30°C. Untreated cells are indicated by the 0 h time point and cells treated with 20 μg/mL TSA for 1 h served as a positive control. Global histone H3 and H4 acetylation was monitored using a polyclonal antibody against acetylated H3 Lys9, 14 or H4 Lys5, 8, and 12. Total Cdc2 levels were used to confirm equal gel loading. D, chk1-HA and chk1-HA rad3Δ mutant cells were treated as indicated and cultured at 30°C for 1 h. Histone H3 acetylation was monitored as in B. Cells were exposed to 120 Jm−2 UV and incubated ± 20 μg/mL TSA.

TSA-Mediated Suppression of UV Sensitivity Occurs Independently of the NER and Recombination Repair Pathways

We investigated the ability of TSA to suppress the UV sensitivity of S. pombe mutants that were checkpoint competent but deficient in nucleotide excision or recombination repair. For these experiments, we used the rad13 mutant that is defective in NER and rhp51 mutants defective in recombination repair. Exposure of both mutants to 120 Jm−2 UV resulted in a significant loss of viability. Culture of these mutants with TSA following UV exposure failed to suppress UV sensitivity (Fig. 5A). TSA nevertheless did suppress the DNA damage sensitivity of a rad13Δ rad1Δ double mutant indicating that the NER pathway is not required for the protective effects observed with HDAC inhibition. These observations suggest that TSA suppresses the UV sensitivity checkpoint mutants but not that of mutants defective in the NER and recombination repair pathways.

Role of Acetylation in the TSA-Mediated Suppression of UV Sensitivity

In S. cerevisiae, exposure to UV results in the rapid increase of global histone H3 and H4 acetylation levels (29, 30). In contrast to S. cerevisiae, exposure of wt S. pombe cells to 120 Jm−2 UV resulted in a rapid decline of global histone H3 and H4 acetylation levels and persisted for up to 2 hours (Fig. 5B and C). The global levels of histone H3 acetylation declined similarly in rad3Δ mutants following exposure to UV (Fig. 5D). TSA induced acetylation of H3 in both wt and rad3Δ mutants following exposure to UV (Fig. 5D). Our observations suggest that global increases in histone acetylation (at least of histones H3 and H4) are not part of the normal response to UV in S. pombe.

Discussion

In the current study, we have extended previous findings from S. cerevisiae (12), demonstrating that inhibition of HDAC activity suppresses the sensitivity of checkpoint deficient strains to DNA damage. Our findings suggest that a major mechanism underlying this is that HDAC inhibition delays progression into mitosis in S. pombe cells, which in a cycling population are largely in G2, and can partially suppress the need for a functional DNA damage checkpoint pathway. In contrast to S. cerevisiae, however, this mitotic delay occurs independently of a functional spindle checkpoint pathway. Furthermore, we have shown that chemical inhibition of HDACs by TSA similarly suppresses the sensitivity of checkpoint mutants to DNA damage, and that the HDAC Clr6 is the TSA target responsible for this effect. HDACis are currently in clinical trials to determine their efficacy as chemosensitizers and radiosensitizers (31). A proper understanding of how HDACis influence the response of cancer cells to DNA damage is required to facilitate effective use of these agents as modulators of drug sensitivity.

Numerous studies have shown that HDACis sensitize cancer cells to the cytotoxic and genotoxic effects of conventional cancer agents (31, 32). The precise mechanisms whereby HDACis sensitize cancer cells to these treatments remain unclear but may involve prevention of effective DNA repair (31). Cancer cells often harbor defects in DNA damage checkpoint pathways and thus have a limited repertoire of responses to deal with genotoxic insults (14). Conceptually, chemosensitization and radiosensitization stratagems seek to attenuate or inhibit the activity of the remaining checkpoints in cancer cells, thus enhancing their sensitivity to genotoxins. Accordingly, agents that abolish DNA damage checkpoints sensitize cancer cells to genotoxic agents (33). HDACis induce cell cycle arrest in both normal and cancer cells (34). This fact raises the possibility that the cell cycle effects of HDACis counteract their chemosensitizing activity. Disruption of an HDAC gene in S. cerevisiae has previously been shown to suppress the sensitivity of checkpoint mutants to UV and HU (12). It is currently unclear if HDAC inhibition will similarly compensate for the loss of checkpoint function in cancer cells. Given that cancer cell progression often selects for the loss of checkpoint pathways (35, 36), a better understanding of the interactions between HDACs and DNA damage response pathways is desirable.

The effects of HDAC inhibition on S. pombe DNA damage checkpoint and repair mutants have not been reported earlier. In the current study, we have characterized the effect of HDAC inhibition with TSA on the sensitivity of S. pombe checkpoint mutants to UV. TSA effectively suppressed the UV sensitivity of rad3, rad1, hus1, chk1, and cds1 chk1 mutants to UV and HU. Deletion of the clr6+ HDAC gene, but not of other HDAC genes, similarly suppressed the HU and UV sensitivity of rad1Δ mutants.

Inhibition of HDAC activity in S. pombe mutants may suppress UV sensitivity through the following mechanisms: (a) activation of an alternative checkpoint, (b) expression of DNA repair proteins not expressed in mutants exposed to UV alone, or (c) enhanced repair resulting from changes in chromatin structure due to increased histone acetylation. Our observations indicate that the suppression of UV sensitivity by TSA neither requires the damage recognition nor the cell cycle checkpoint activities of checkpoint proteins, because the sensitivity of rad3 mutants is also suppressed (Fig. 1). We noted that TSA also suppressed the characteristic increase in septating cells following UV exposure that occurs in rad3, rad1Δ, and chk1Δ mutants (Fig. 2A; refs. 23, 24). The mitogen-activated protein kinase–activated protein kinase Srk1 has been shown to be capable of inducing cell cycle arrest in G2 (37). Srk1 is activated by the Sty1 stress-activated protein kinase, a homologue of mammalian p38SAPK2, following cellular exposure to stress (37, 38). Sty1 has itself been shown to be involved in the response of S. pombe cells to UV exposure and sty1 mutants are moderately sensitive to this agent (39). Deletion of sty1+ in a rad1Δ mutant to UV did not prevent the suppressive effect of TSA following exposure. Similarly, deletion of srk1+ in a rad1Δ background did not suppress the protective effect of TSA or result in increased sensitivity to UV (Fig. 5). In S. cerevisiae, the suppression of UV sensitivity induced by the inhibition of HDAC activity requires an intact spindle checkpoint (12). Codeletion of the spindle checkpoint regulator gene mad2+ did not affect the ability of TSA to suppress UV sensitivity in S. pombe rad1Δ mutants (Fig. 5). We conclude therefore that in fission yeast, the suppression of UV sensitivity by TSA does not involve activation of either of these alternative cell cycle checkpoints. TSA failed to suppress the sensitivity of rad13Δ mutants, defective in NER, and of an rhp51Δ mutant, defective in recombination repair (Fig. 5). These mutants arrest normally following exposure to UV but fail to repair UV-induced DNA damage (40). TSA, thus specifically suppresses the DNA damage sensitivity of checkpoint mutants, but not of DNA repair mutants.

TSA suppressed the UV sensitivity of chk1Δ mutants (Fig. 1). According to current models, the UV sensitivity of chk1 mutants results from their inability to undergo G2 arrest following DNA damage. These mutants thus undergo mitosis in the presence of damaged DNA (41). We postulate that TSA suppresses UV sensitivity by delaying progression into mitosis, thus abrogating the need for checkpoint induction. The precise mechanisms by which TSA delays mitotic progression remain unclear but are clearly linked to the increased global acetylation induced by this agent. Studies in mammalian cells suggest, however, that the prevention of entry into mitosis as well as its deregulation is indeed a common consequence of HDAC inhibition (42). TSA has been shown to suppress the expression of mitotic regulators such as cyclin B1 and Plk1 in human cancer cells (43). In S. pombe, osmotic stress has been shown to delay mitosis independently of mad2+ and rad3+ by enhancing the affinity of Cut2 (securin) for Cut1 (separase; ref. 44). We are currently investigating if HDACis prevent the initiation of mitosis by similar mechanisms in S. pombe.

It is increasingly evident that the modulation of histone acetylation by histone acetyl transferases and HDACs is important for the repair of DNA damage (45). Histone acetylation enhances DNA repair, and S. cerevisiae gcn5Δ mutants are mildly sensitive to UV (46). In S. pombe, loss of Clr6 HDAC activity or deletion of its associated cofactors results in increased sensitivity to higher doses of UV (6). Histone acetylation is believed to allow efficient access of repair proteins via its effects on transcription and chromatin architecture (45). Interestingly, we observed that exposure to UV does not induce increased, but rather a moderately decreased global histone acetylation in S. pombe. Indeed, global deacetylation seems to accompany cell cycle arrest in S. pombe irrespective of cell cycle phase (Supplementary Fig. S1C; ref. 47). Our studies show that HDAC inhibition does not suppress the sensitivity of mutants with DNA repair defects. They do not, however, exclude the possibility that TSA enhances the rate of DNA repair as a consequence of global histone acetylation. We are currently investigating this possibility.

In mammals, a defect within the ATM-regulated checkpoint pathway sensitizes cells to DNA damage but also predisposes toward the development of cancer. It is possible that the modulation of HDAC activity in cells with defective checkpoint pathways may contribute toward genetic instability by facilitating their survival. Our findings also provide further support for the notion that the use of HDACis as chemosensitizers or radiosensitizers may be contraindicated in tumors with defective DNA damage checkpoints (12).

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Acknowledgments

We thank Beáta Grallert, Erik Boye, Karl Ekwall, Shiv Grewal, Nancy Walworth, and the Yeast Genetic Resource Centre for the S. pombe strains.

Footnotes

  • Grant support: Swedish Cancer Fund (07-0759), the Chemical Biology Platform at the University of Gothenburg, and by an EMBO long-term postdoctoral fellowship (J.P. Alao).

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Note: Supplementary material for this article is available at Molecular Cancer Therapeutics Online (http://mct.aacrjournals.org/).

  • J.P. Alao was the recipient of an EMBO Long Term Fellowship.

  • ↵1http://www-rcf.usc.edu/~forsburg/yeast-flow-protocol.html

    • Received March 9, 2009.
    • Revision received May 13, 2009.
    • Accepted June 8, 2009.
  • © 2009 American Association for Cancer Research.

References

  1. ↵
    1. Humphrey T
    . DNA damage and cell cycle control in Schizosaccharomyces pombe. Mutat Res 2000;451:211–26.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Koundrioukoff S,
    2. Polo S,
    3. Almouzni G
    . Interplay between chromatin and cell cycle checkpoints in the context of ATR/ATM-dependent checkpoints. DNA Repair 2004;3:969–78.
    OpenUrlPubMed
  3. ↵
    1. Gallinari P,
    2. Di Marco S,
    3. Jones P,
    4. Pallaoro M,
    5. Steinkuhler C
    . HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res 2007;17:195–211.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Smerdon MJ,
    2. Lan SY,
    3. Calza RE,
    4. Reeves R
    . Sodium butyrate stimulates DNA repair in UV-irradiated normal and xeroderma pigmentosum human fibroblasts. J Biol Chem 1982;257:13441–7.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Jazayeri A,
    2. Falck J,
    3. Lukas C,
    4. et al
    . ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 2006;8:37–45.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Nakayama J,
    2. Xiao G,
    3. Noma K,
    4. et al
    . Alp13, an MRG family protein, is a component of fission yeast Clr6 histone deacetylase required for genomic integrity. EMBO J 2003;22:2776–87.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Bolden JE,
    2. Peart MJ,
    3. Johnstone RW
    . Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006;5:769–84.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Rasheed WK,
    2. Johnstone RW,
    3. Prince HM
    . Histone deacetylase inhibitors in cancer therapy. Expert Opin Investig Drugs 2007;16:659–78.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Camphausen K,
    2. Cerna D,
    3. Scott T,
    4. et al
    . Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Int J Cancer 2005;114:380–6.
    OpenUrlCrossRefPubMed
    1. Cerna D,
    2. Camphausen K,
    3. Tofilon PJ
    . Histone deacetylation as a target for radiosensitization. Curr Top Dev Biol 2006;73:173–204.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Kim MS,
    2. Baek JH,
    3. Chakravarty D,
    4. Sidransky D,
    5. Carrier F
    . Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA). Exp Cell Res 2005;306:94–102.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Scott KL,
    2. Plon SE
    . Loss of Sin3/Rpd3 histone deacetylase restores the DNA damage response in checkpoint-deficient strains of Saccharomyces cerevisiae. Mol Cell Biol 2003;23:4522–31.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Ahmed M,
    2. Rahman N
    . ATM and breast cancer susceptibility. Oncogene 2006;25:5906–11.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Zhou BB,
    2. Bartek J
    . Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nature Rev 2004;4:216–25.
    OpenUrlCrossRef
  14. ↵
    1. Alao JP,
    2. Sunnerhagen P
    . Rad3 and Sty1 function in S. pombe: an integrated response to DNA damage and environmental stress? Mol Microbiol 2008;68:246–54.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Asp E,
    2. Sunnerhagen P
    . Mkp1 and Mkp2, two MAPKAP-kinase homologues in Schizosaccharomyces pombe, interact with the MAP kinase Sty1. Mol Genet Genom 2003;268:585–97.
    OpenUrlPubMed
  16. ↵
    1. Bähler J,
    2. Wu JQ,
    3. Longtine MS,
    4. et al
    . Heterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe. Yeast 1998;14:943–51.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Dunaway S,
    2. Walworth NC
    . Assaying the DNA damage checkpoint in fission yeast. Methods 2004;33:260–3.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Sazer S,
    2. Sherwood SW
    . Mitochondrial growth and DNA synthesis occur in the absence of nuclear DNA replication in fission yeast. J Cell Sci 1990;97:509–16.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Murakami H,
    2. Okayama H
    . A kinase from fission yeast responsible for blocking mitosis in S phase. Nature 1995;374:817–9.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Enoch T,
    2. Nurse P
    . Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication. Cell 1990;60:665–73.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Enoch T,
    2. Carr AM,
    3. Nurse P
    . Fission yeast genes involved in coupling mitosis to completion of DNA replication. Genes Dev 1992;6:2035–46.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Jimenez G,
    2. Yucel J,
    3. Rowley R,
    4. Subramani S
    . The rad3+ gene of Schizosaccharomyces pombe is involved in multiple checkpoint functions and in DNA repair. Proc Natl Acad Sci U S A 1992;89:4952–6.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Kanter-Smoler G,
    2. Knudsen KE,
    3. Jimenez G,
    4. Sunnerhagen P,
    5. Subramani S
    . Separation of phenotypes in mutant alleles of the Schizosaccharomyces pombe cell cycle checkpoint gene rad1+. Mol Biol Cell 1995;6:1793–805.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. McCollum D,
    2. Gould KL
    . Timing is everything: regulation of mitotic exit and cytokinesis by the MEN and SIN. Trends Cell Biol 2001;11:89–95.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Wolfe BA,
    2. Gould KL
    . Split decisions: coordinating cytokinesis in yeast. Trends Cell Biol 2005;15:10–8.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Mikhailov A,
    2. Shinohara M,
    3. Rieder CL
    . The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis. Cell Cycle 2005;4:57–62.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Lopez-Aviles S,
    2. Lambea E,
    3. Moldon A,
    4. et al
    . Activation of Srk1 by the MAP kinase Sty1/Spc1 precedes its dissociation from the kinase and signals its degradation. Mol Biol Cell 2008;19:1670–9.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Yu Y,
    2. Teng Y,
    3. Liu H,
    4. Reed SH,
    5. Waters R
    . UV irradiation stimulates histone acetylation and chromatin remodeling at a repressed yeast locus. Proc Natl Acad Sci U S A 2005;102:8650–5.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Yu Y,
    2. Waters R
    . Histone acetylation, chromatin remodelling and nucleotide excision repair: hint from the study on MFA2 in Saccharomyces cerevisiae. Cell Cycle 2005;4:1043–5.
    OpenUrlPubMed
  30. ↵
    1. Camphausen K,
    2. Tofilon PJ
    . Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J Clin Oncol 2007;25:4051–6.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Karagiannis TC,
    2. El-Osta A
    . The paradox of histone deacetylase inhibitor-mediated modulation of cellular responses to radiation. Cell Cycle 2006;5:288–95.
    OpenUrlPubMed
  32. ↵
    1. Kawabe T
    . G2 checkpoint abrogators as anticancer drugs. Mol Cancer Therapeut 2004;3:513–9.
    OpenUrl
  33. ↵
    1. Xu WS,
    2. Parmigiani RB,
    3. Marks PA
    . Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007;26:5541–52.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Bartek J,
    2. Bartkova J,
    3. Lukas J
    . DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007;26:7773–9.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Tommiska J,
    2. Bartkova J,
    3. Heinonen M,
    4. et al
    . The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Oncogene 2008;27:2501–6.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Lopez-Aviles S,
    2. Grande M,
    3. Gonzalez M,
    4. et al
    . Inactivation of the Cdc25 phosphatase by the stress-activated Srk1 kinase in fission yeast. Mol Cell 2005;17:49–59.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Smith DA,
    2. Toone WM,
    3. Chen D,
    4. et al
    . The Srk1 protein kinase is a target for the Sty1 stress-activated MAPK in fission yeast. J Biol Chem 2002;277:33411–21.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Degols G,
    2. Russell P
    . Discrete roles of the Spc1 kinase and the Atf1 transcription factor in the UV response of Schizosaccharomyces pombe. Mol Cell Biol 1997;17:3356–63.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. McCready SJ,
    2. Osman F,
    3. Yasui A
    . Repair of UV damage in the fission yeast Schizosaccharomyces pombe. Mutat Res 2000;451:197–210.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Walworth NC,
    2. Bernards R
    . rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science 1996;271:353–6.
    OpenUrlAbstract
  41. ↵
    1. Mikhailov A,
    2. Shinohara M,
    3. Rieder CL
    . Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. J Cell Biol 2004;166:517–26.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Noh EJ,
    2. Lim DS,
    3. Jeong G,
    4. Lee JS
    . An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner. Biochem Biophys Res Comm 2009;378:326–31.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Kawasaki Y,
    2. Nagao K,
    3. Nakamura T,
    4. Yanagida M
    . Fission yeast MAP kinase is required for the increased securin-separase interaction that rescues separase mutants under stresses. Cell Cycle 2006;5:1831–9.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Gong F,
    2. Kwon Y,
    3. Smerdon MJ
    . Nucleotide excision repair in chromatin and the right of entry. DNA Repair 2005;4:884–96.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Teng Y,
    2. Yu S,
    3. Waters R
    . The mapping of nucleosomes and regulatory protein binding sites at the Saccharomyces cerevisiae MFA2 gene: a high resolution approach. Nucl Acids Res 2001;29:E64–4.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Kunoh T,
    2. Habu T,
    3. Matsumoto T
    . Involvement of fission yeast Clr6-HDAC in regulation of the checkpoint kinase Cds1. Nucl Acids Res 2008;36:3311–9.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Dahlkvist A,
    2. Kanter-Smoler G,
    3. Sunnerhagen P
    . The RCK1 and RCK2 protein kinase genes from Saccharomyces cerevisiae suppress cell cycle checkpoint mutations in Schizosaccharomyces pombe. Mol Gen Genet 1995;246:316–26.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Bjerling P,
    2. Silverstein RA,
    3. Thon G,
    4. Caudy A,
    5. Grewal S,
    6. Ekwall K
    . Functional divergence between histone deacetylases in fission yeast by distinct cellular localization and in vivo specificity. Mol Cell Biol 2002;22:2170–81.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    1. Olsson TGS,
    2. Ekwall K,
    3. Allshire RC,
    4. Sunnerhagen P,
    5. Partridge JF,
    6. Richardson WA
    . Genetic characterisation of hda1+, a putative fission yeast histone deacetylase gene. Nucl Acids Res 1998;26:3247–54.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Molecular Cancer Therapeutics: 8 (9)
September 2009
Volume 8, Issue 9
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay
John P. Alao, Jeanette Olesch and Per Sunnerhagen
Mol Cancer Ther September 1 2009 (8) (9) 2606-2615; DOI: 10.1158/1535-7163.MCT-09-0218

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay
John P. Alao, Jeanette Olesch and Per Sunnerhagen
Mol Cancer Ther September 1 2009 (8) (9) 2606-2615; DOI: 10.1158/1535-7163.MCT-09-0218
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • A Novel TRAIL-Based Technology for Tumor Therapy
  • Trastuzumab Targeting of Metastatic Esophageal Cancer
  • Mcl-1 Determines the Fate of KSP-Inhibited Cells
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement